Kolaja Carey OConnor 4
4 · Revance Therapeutics, Inc. · Filed Mar 2, 2021
Insider Transaction Report
Form 4
Kolaja Carey OConnor
Director
Transactions
- Award
Stock Option (Right to buy)
2021-03-01+11,417→ 11,417 totalExercise: $26.80Exp: 2031-02-28→ Common Stock (11,417 underlying) - Award
Common Stock
2021-03-01+6,294→ 6,294 total
Footnotes (2)
- [F1]Represents an initial restricted stock award (the "RSA") granted pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy (the "Compensation Policy"). The shares underlying the RSA shall vest on the one year anniversary of the date of grant, March 1, 2022, subject to Ms. Kolaja's Continuous Service (as defined the Issuer's 2014 Equity Incentive Plan (the "Plan")) through such vesting date.
- [F2]The shares subject to the stock option shall vest on the one year anniversary of the date of grant, March 1, 2022, subject to Ms. Kolaja's' Continuous Service (as defined in the Plan) through such vesting date. The stock option represents an initial grant pursuant to the Compensation Policy.